Related Experiment Video

Updated: May 13, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

[Driver gene mutation and targeted therapy of lung cancer]

Tetsuya Mitsudomi1

  • 1Division of Thoracic Surgery, Dept. of Surgery, Kinki University Faculty of Medicine, Osaka-Sayama, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 20, 2013
PubMed

Insights

Targeted cancer therapies focus on "driver genes" essential for tumor growth. Epidermal growth factor receptor (EGFR) inhibitors significantly improve lung cancer survival, shifting treatment paradigms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Context:

  • Cancer cells rely on specific genetic alterations, termed "drive genes," for survival and proliferation.
  • Targeting these critical mutations offers a highly effective therapeutic strategy.

Purpose:

  • To review the development and impact of targeted therapies in lung cancer treatment.
  • To highlight the success of Epidermal Growth Factor Receptor (EGFR)-tyrosine kinase inhibitors (TKIs) and other targeted agents.

Summary:

  • EGFR-TKIs (e.g., gefitinib, erlotinib) have demonstrated superior progression-free survival compared to traditional chemotherapy in lung cancer patients with EGFR mutations.
  • Crizotinib's approval for anaplastic lymphoma kinase (ALK) gene translocations signifies progress in personalized lung cancer treatment.
  • Ongoing research targets other driver mutations like ROS1, RET, and HER2, expanding personalized therapeutic options.

Impact:

  • EGFR-TKI therapy has revolutionized lung cancer treatment, moving it towards a more personalized and effective approach.
  • Targeted therapies are transforming lung cancer from an acute, fatal disease into a more manageable chronic condition.
  • These advancements hold promise for improving patient outcomes and potentially achieving cures.

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...